Company: DARE
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001401914-25-000044
Chunk: 44

Company: Dare Bioscience, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 44
---
 approved by the Company's stockholders on June 23, 2022, and became effective as of that date. The 2022 Plan provides for the grant of stock-based incentive awards to employees, directors, consultants, and advisors. As of June 30, 2025, the number of shares of common stock authorized for issuance under the 2022 Plan was 1,349,085, which is the sum of:(a)227,283 shares available for awards that may be granted under the 2022 Plan, plus(b)728,543 shares underlying awards granted under the 2022 Plan, plus(c)393,259 shares underlying awards granted under the Amended 2014 Plan, which if they expire, terminate or are otherwise forfeited will become available for issuance under the 2022 Plan.Options granted are exercisable at various dates as determined upon grant and will expire no more than ten years from their date of grant. Stock options generally vest over a four-year term. The exercise price of each option is determined by the Company's board of directors or its compensation committee based on the estimated fair value of the Company's stock on the date of grant. See Note 13, Subsequent Events, for information regarding an amendment to the 2022 Plan.Summary of Stock Option ActivityThe table below summarizes stock option activity under the Company's stock incentive plans and related information for the six months ended June 30, 2025. The exercise price of all options granted during the six months ended June 30, 2025 was equal to the market value of the Company’s common stock on the date of grant. As of June 30, 2025, unamortized stock-based compensation expense of approximately $2.2 million will be amortized over a weighted average period of 1.21 years. The number of shares of common stock available for future awards granted under the 2022 Plan as of June 30, 2025 was 227,283.Number of SharesWeighted AverageExercise PriceOutstanding at December 31, 2024883,334 $14.58 Granted296,650 3.27 Exercised— Cancelled/forfeited(765)3.18 Expired(57,417)20.90 Outstanding at June 30, 20251,121,802 $11.27 Exercisable at June 30, 2025648,652 $15.21 

17

The weighted